Brief: Lexeo Therapeutics May Offer And Sell Shares Of Common Stock Of Up To $75 Million - SEC Filing
24/03/2025 12:03
March 24 (Reuters) - Lexeo Therapeutics Inc LXEO.O: LEXEO THERAPEUTICS: MAY OFFER AND SELL SHARES OF OUR COMMON STOCK OF UP TO $75 MILLION - SEC FILING Source text: [ID:n0001193125-25-060883] Further company coverage: LXEO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexeo Therapeutics
See all newsBrief: Lexeo Therapeutics Enters Into Agreement To Acquire Mantle Therapeutics And Announces Multiple New Strategic Collaborations To Expand Leadership In Friedreich Ataxia
Brief: Lexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (Rmat) Designation For Lx2020
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
U.S. STOCKS ON THE MOVE-Datadog, Terawulf
Lexeo rises as co sets late-stage trial plan for gene therapy in rare heart disease